Yann-Jinn Lee Selected Research

TCGA-specific type II deoxyribonucleases

4/2010

Comparing the Southern blot method and polymerase chain reaction product analysis for chimeric RCCX detection in CYP21A2 deficiency.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yann-Jinn Lee Research Topics

Disease

7	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2021 - 05/2003
6	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 01/2021 - 01/2007
5	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2016 - 04/2006
5	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2016 - 04/2006
4	Biliary Atresia 03/2012 - 01/2010
4	Congenital Adrenal Hyperplasia (Hyperplasia, Congenital Adrenal) 04/2010 - 05/2004
3	Genetic Predisposition to Disease (Genetic Predisposition) 01/2021 - 04/2007
3	Cholelithiasis 04/2013 - 07/2003
2	Type 2 Diabetes Mellitus (MODY) 12/2021 - 01/2014
2	COVID-19 related pediatric multisystem inflammatory disease 01/2021 - 01/2021
2	COVID-19 01/2021 - 01/2021
2	Thyroid Diseases (Thyroid Disease) 01/2020 - 01/2016
2	Neoplasms (Cancer) 02/2017 - 11/2005
2	Graves Disease (Basedow Disease) 03/2011 - 09/2003
2	Autoimmune Diseases (Autoimmune Disease) 08/2008 - 04/2004
1	Vitamin D Deficiency 01/2022
1	Cognitive Dysfunction 01/2021
1	Infections 01/2021
1	Precocious Puberty 01/2021
1	Shock 01/2021
1	Vasculitis (Vasculitides) 01/2021
1	Dehydration (Water Stress) 01/2020
1	Celiac Disease (Celiac Sprue) 01/2020
1	Pseudohypoparathyroidism 01/2014
1	Pseudopseudohypoparathyroidism 01/2014
1	Nephrolithiasis 01/2014
1	Gallstones (Gallstone) 04/2013
1	Hashimoto Disease (Thyroiditis, Hashimoto) 01/2013
1	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 03/2012
1	Permanent Neonatal Diabetes Mellitus 07/2009
1	Bacterial Infections (Bacterial Infection) 08/2008
1	Rheumatoid Arthritis 04/2007
1	Carcinogenesis 04/2006
1	Squamous Cell Carcinoma of Head and Neck 11/2005
1	Communicable Diseases (Infectious Diseases) 11/2005
1	Insulin Resistance 03/2005
1	Androgen-Insensitivity Syndrome (Testicular Feminization) 03/2005

Drug/Important Bio-Agent (IBA)

4	HLA Antigens (Human Leukocyte Antigens)IBA 01/2021 - 04/2006
4	Insulin (Novolin)FDA Link 03/2018 - 03/2005
4	Interleukin-18 (Interleukin 18)IBA 07/2013 - 05/2011
4	Immunologic Factors (Immunomodulators)IBA 04/2011 - 01/2007
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 04/2007
3	AntigensIBA 03/2018 - 01/2014
3	HLA-DRB1 Chains (HLA DRB1)IBA 04/2007 - 04/2006
3	micaIBA 01/2004 - 07/2003
2	CytokinesIBA 01/2021 - 11/2005
2	InterferonsIBA 01/2021 - 01/2013
2	Proteins (Proteins, Gene)FDA Link 01/2016 - 04/2011
2	Glucose (Dextrose)FDA LinkGeneric 01/2014 - 03/2005
2	Interleukin-4 (Interleukin 4)IBA 03/2011 - 01/2008
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2010 - 07/2008
1	Vitamin D FDA LinkGeneric 01/2022
1	Parathyroid Hormone (Parathormone)IBA 01/2022
1	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 01/2021
1	HLA-B Antigens (HLA-B)IBA 01/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021
1	Blood Group Antigens (Blood Groups)IBA 01/2021
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2021
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2021
1	Interleukin-17 (Interleukin 17)IBA 01/2021
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2021
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2021
1	Interleukin-10 (Interleukin 10)IBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2021
1	HLA-DQ Antigens (HLA-DQ)IBA 01/2020
1	HLA-DQ8 antigenIBA 01/2020
1	NitrogenIBA 01/2020
1	thyrotropin-binding inhibitory immunoglobulinIBA 01/2020
1	AntibodiesIBA 01/2020
1	Protein Glutamine gamma Glutamyltransferase 2IBA 01/2020
1	SodiumIBA 01/2020
1	Urea (Carbamide)FDA LinkGeneric 01/2020
1	AutoantibodiesIBA 03/2018
1	Class 8 Receptor-Like Protein Tyrosine PhosphatasesIBA 03/2018
1	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 03/2018
1	Inositol 1,4,5-Trisphosphate Receptors (Inositol Triphosphate Receptor)IBA 02/2017
1	Purinergic P2X7 ReceptorsIBA 12/2016
1	1- nitro- 9- (2- dihydroxyethylaminoethylamino)acridine (C 835)IBA 12/2016
1	HLA-DPB1 antigen (HLA DPB1)IBA 09/2015
1	KATP ChannelsIBA 01/2014
1	HLA-G Antigens (HLA G)IBA 01/2014
1	5-phenylpent-4-enyl-1-hydroperoxideIBA 01/2014
1	Therapeutic UsesIBA 01/2014
1	picotamideIBA 07/2013
1	DNA (Deoxyribonucleic Acid)IBA 04/2013
1	TCGA-specific type II deoxyribonucleasesIBA 04/2010
1	Interferon-gamma (Interferon, gamma)IBA 01/2010
1	CD40 Ligand (CD40L)IBA 09/2008
1	Antigen-Antibody Complex (Immune Complex)IBA 08/2008
1	Steroid 21-Hydroxylase (21 Hydroxylase)IBA 04/2008
1	EpitopesIBA 04/2007
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2005
1	Steroid 11-beta-Hydroxylase (11 beta-Hydroxylase)IBA 04/2005
1	SteroidsIBA 04/2005
1	Androgen Receptors (Androgen Receptor)IBA 03/2005

Therapy/Procedure

6	Glycemic Control 12/2021 - 10/2004
3	Therapeutics 01/2014 - 05/2003
2	Immunotherapy 01/2021 - 01/2021
1	Liver Transplantation 03/2012